SCHEMBL10569299

SCHEMBL10569299

COc1ccc(-c2cc(=O)n(C)c(=O)n2C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ PKM P14618 2/20 0.48
▸ KDM4E B2RXH2 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ NR4A2 P43354 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ ADORA2B P29275 2/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ EGFR P00533 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10567037 0.83 ALDH1A1 (0.43) ALDH1A1PKMKDM4EKMT2ABACE1
SCHEMBL10564839 0.78 HPGD (0.51) ALDH1A1KDM4EKMT2ASMN1; SMN2HPGD
SCHEMBL10563856 0.78 ALDH1A1 (0.44) ALDH1A1PKMKDM4EKMT2ASMN1; SMN2
SCHEMBL1420047 0.76 MEN1 (0.59) ALDH1A1PKMKDM4EKMT2ABACE1
SCHEMBL10564660 0.75 CYP19A1 (0.47) ALDH1A1KDM4EHPGDTSHRRXFP1
SCHEMBL10364624 0.74 L3MBTL1 (0.40) ALDH1A1KDM4EHPGDNPSR1MAPT
SCHEMBL17375980 0.74 HRH3 (0.49) ALDH1A1PKMKDM4EKMT2ABACE1
SCHEMBL10656338 0.73 MAPT (0.50) ALDH1A1KDM4EKMT2ASMN1; SMN2HPGD
SCHEMBL10564768 0.73 MAPT (0.50) ALDH1A1KDM4EKMT2ASMN1; SMN2HPGD
SCHEMBL10563793 0.72 AHR (0.43) ALDH1A1PKMKDM4EKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4649142-A 3,4-dihydro-1,3-disubstituted-6-(substituted phenylimino)-2(1H)-pyrimidinone useful as cardiotonic agent and anti-allergic agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-03-10 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0166564-A2 Pyrimidone derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback